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Abstract
Background: Single nucleotide polymorphism (SNP) genotyping is increasingly being utilized for molecular typing
of pathogens and is cost-effective, especially for large numbers of isolates. The goals of this study were 1) to
develop and validate a SNP assay panel for genetic analysis of Blastomyces spp., 2) ascertain whether microsatellite
genotyping and the SNP genotyping with the developed panel resolve identical genetic groups, and 3) explore the
utility of SNPs for examining phylogenetic and virulence questions in humans.
Methods: Three hundred sixty unique Blastomyces spp. isolates previously genotyped with microsatellite markers
were genotyped with the MassARRAY® SNP genotyping system (Agena Bioscience™, San Diego, CA), for a custom
panel of 28 SNPs. Clinical presentation data was analyzed for association with SNP variants.
Results: Three hundred twenty-three Blastomyces spp. isolates (90 %) were successfully genotyped by SNP analysis,
with results obtained for at least 27 of 28 assays. For 99.7 % of isolates tested by both genotyping methods,
microsatellite genetic group assignment correlated with species assignment based on internal transcribed spacer 2
(ITS2) genotyping, with Group 1 (Gr 1) being equivalent to B. gilchristii and Group 2 (Gr 2) being equivalent to B.
dermatitidis. Thirteen isolates were genetic hybrids by one or both methods of genotyping and were difficult to
assign to a particular genetic group or species. Fifteen SNP loci showed significantly different alleles in cases of
pulmonary vs disseminated disease, at a p-value of <0.01 or less.
Conclusions: This study is the largest genotyping study of Blastomyces spp. isolates and presents a new
method for genetic analysis with which to further explore the relationship between the genetic diversity in
Blastomyces spp. and clinical disease presentation. We demonstrated that microsatellite Gr 1 is equivalent to
B. gilchristii and Gr 2 is equivalent to B. dermatitidis. We also discovered potential evidence of infrequent
recombination between the two Blastomyces spp. Several Blastomyces spp. SNPs were identified as associated
with dissemination or pulmonary disease presentation, but additional work is needed to examine virulence
SNPs separately within B. dermatitidis and B. gilchristii.
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Background
Blastomyces spp. are thermally dimorphic fungi endemic
to regions of North America with sporadic cases in
India, Africa, and South America [1–4]. Genetic typing
of Blastomyces spp. isolates using microsatellite markers
revealed two distinct genetic groups [5]. Later, significant
associations between microsatellite genetic group and
clinical disease phenotype were demonstrated in humans,
with genetic Gr 1 being associated with isolated pulmon-
ary disease and Gr 2 being associated with cases of dis-
seminated disease [6]. More recently, multilocus sequence
typing of Blastomyces spp. isolates has led to the proposal
of a cryptic species, B. gilchristii, within the group his-
torically referred to as B. dermatitidis [7]. In that study,
46 nucleotide polymorphisms were identified within 7
gene regions, with 12 SNPs being determined as diag-
nostic between B. gilchristii and B. dermatitidis. Geno-
typing of a small number of isolates by both methods
indicates that B. gilchristii, the newly proposed species,
may be equivalent to microsatellite genetic Group 1
with B. dermatitidis being equivalent to microsatellite
genetic Gr 2 [7, 8]. This suggests that clinical disease
variation is potentially associated with species-specific
genetic diversity.
SNPs are a valuable tool for studying recombination, re-
arrangement, relatedness and other genetic processes. In
humans, SNPs occur at approximately 1 SNP/kilobase
throughout the genome and are responsible for most
monogenic disorders [9]. Due to the versatility of SNPs to
examine varying genetic questions, they are increasingly
being utilized for molecular typing of pathogens [10–13].
SNP genotyping is easily suited to high-throughput testing
which is more cost-effective than microsatellite typing
and/or Sanger sequencing. In the case of Blastomyces, the
ability to determine the species of an isolate from a small
number of SNPs is particularly useful given the established
associations with clinical features, such as disease dissem-
ination. The goals of this study were 1) to develop and
validate a SNP assay panel for genetic analysis of Blasto-
myces spp. isolates, 2) ascertain whether microsatellite
genotyping and SNP genotyping with the developed panel
resolve similar phylogenetic groups, and 3) explore the
utility of SNPs for examining virulence associations in
cases of human disease.
Methods
Isolates
Three hundred sixty unique Blastomyces spp. isolates
previously extracted [6] and genotyped using 27 poly-
morphic microsatellite markers [7], were selected for
this study. Only isolates with complete microsatellite
typing for all 27 markers were included in the study.
These included: 295 human isolates, 51 canine isolates,
8 environmental isolates, 4 feline isolates, 1 equine
isolate, and 1 alpaca isolate. Twenty isolates were gifted
to us from other researchers, three isolates were pur-
chased from ATCC (26199, 18187, and 18188), and the
remaining isolates were obtained as part of clinical diag-
nosis at Diagnostic Services of Manitoba (n = 28) or
Marshfield Labs™ (n = 309). All isolates were identified
as Blastomyces spp. using standard methods, which in-
cluded culture of the mold form on brain-heart infu-
sion agar with blood at 25 °C and conversion to the
yeast form when incubated in Middlebrook 7H9 broth
at 35 °C. Clinical presentation and mortality data was
previously abstracted on 310 of these cases for a former
study [6]. Research protocols were approved by the
Marshfield Clinic Research Foundation Institutional
Review Board. Waiver of informed consent was ob-
tained for retrospective review of clinical information,
specimen collection and genotyping.
SNP assay development and genotyping
Blastomyces spp. isolates were genotyped with the Mas-
sARRAY® SNP genotyping system (Agena Bioscience™,
San Diego, CA), for a custom panel of 28 single nucleo-
tide polymorphisms (SNPs). To design our custom SNP
assay, 21 gene regions were investigated for appropriate
polymorphism targets that could be multiplexed into a
single-well, high-throughput genotyping platform. The
gene regions evaluated included known and potential
virulence and housekeeping genes in both coding and
non-coding areas. Alignments for each gene target were
obtained from publicly available sources, National Center
for Biotechnology Information (NCBI) GenBank (available
at http://www.ncbi.nlm.nih.gov/genbank/) and the Broad
Institute [14], and sequence data generated in our lab
(data not shown). One hundred and eight different SNPs
and insertion/deletions (INDELs) within 21 gene regions
were evaluated for appropriate PCR and extension primer
combinations. Allowing the design software to assemble
multiple iterations of possible target combinations, a 28-
plex assay was chosen that included at least one target
from each of 19 gene regions (Table 1).
Two-Ten ng of each deoxyribonucleic acid (DNA)
sample was amplified in a 5 μL reaction containing 1 U
of Taq enzyme, 1X Buffer, 2.0 mM MgCl2, 500 μM each
dNTP and 0.1 μM of each gene-specific forward and re-
verse primer (Additional file 1). Cycling conditions
were 2 min at 94 °C followed by 45 cycles of 30 s at
94 °C, 30 s at 56 °C, 60 s at 72 °C and a final extension
time of 5 min at 72 °C. After PCR amplification, shrimp
alkaline phosphatase was added to the samples and in-
cubated for 40 min at 37 °C. Extension primers, iPLEX
enzyme, buffer, and termination mixture of mass-
modified di-deoxynucleotide triphosphates were added
to initiate the iPLEX primer extension reaction. The
cycling conditions consisted of a two-step, 200 short
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cycle program with one loop of 5 cycles inside a loop of
40 cycles. The sample was denatured at 94 °C for 30 s,
followed by 5 cycles of annealing at 52 °C for 5 s and
extended at 80 °C for 5 s. The five annealing and exten-
sion cycles with the single denaturing step was repeated
40 times, for a total number of 200 annealing and
extension cycles. MassEXTEND clean resin was added
to each reaction to remove extraneous salts that inter-
fere with matrix assisted laser desorption ionization
time-of-flight (MALDI-TOF) analysis. Fifteen nL of the
sample was transferred from the plate and spotted onto
a matrix pad of the SpectroCHIP array. Genotypes were
determined by mass correlations on the MALDI-TOF
mass spectrometer.
SNP panel validation
Twelve isolates (9 human isolates, 1 environmental isolate,
1 canine isolate, and 1 alpaca isolate) with previously
obtained sequence data (available at NCBI, Table 1, and
generated in our lab, data not shown), demonstrating
known allelic diversity, were chosen for assay validation,
to include examples of expected alleles at a subset of the
targets. These 12 validation samples had been sequenced
in-house for previous studies and 102 SNP alleles were
known on these samples at the 28 loci included in the
design. Comparison of previous in-house sequencing re-
sults with our iPLEX SNP genotyping was used to validate
the accuracy of calls. Each validation sample was assayed
in multiple batches of testing to confirm the precision and
Table 1 Single nucleotide polymorphisms (SNPs) included in the genotyping panel




Microsatellite 1.32a N/A non-gene region 132GAx11_108 N/Ab






ADP-ribosylation factor Vesicular trafficking Gene ARF_374 AY013310.1
ADP-ribosylation factor 6 5′ UTR N/A Untranslated region arf6_240 JN561794.1





alpha tubulin Morphogenesis Gene TUB1_18
TUB1_277
JN562331.1
orotidine 5′-phosphate decarboxylase Biosynthesis of pyrimidines Gene pyrF_21
pyrF_99
JN562191.1
chitin synthase Cell Wall/exoskeleton scaffolding Gene chs2_203
chs2_290
JN561872.1
fatty acid desaturase Membrane fluidity, thermotolerance Gene fads_622 JN562028.1
internal
transcribed spacer 2 of rDNA
N/A Gene ITS2_19e JN562151.1
urease Ammonia production, protection
from phagocytes
Gene urease_1503 XM_002623809.1





beta-glucosidase Breaks down cellulose Gene b-glucosidase_966
b-glucosidase_1243
XM_002621346.1
septin-1 Filament formation, scaffold,
sporulation
Gene septin1_1251 XM_002628186.1
heat shock protein Thermotolerance Gene hsp_764 XM_002624824.1
DNA Lyase DNA repair, Flanks mating locus Gene APN2_1016 XM_002623165.1
Acetate- coA ligase Metabolism Gene CoAligase_346 XM_002626273.1
tryptophan tRNA ligase ATP binding Gene trypt-lig_922 XM_002620210.1
tyrosinase Involved in melanin synthesis Gene tyrosinase_759 XM_002623880.1
aMicrosatellite locus 5, Meece et al. Applied and Environmental Microbiology 17:5123–5131
bSequence not publically available
cBrandhorst et al. J Biol Chem 275:7925–7934 and Wüthrich et al. Med Mycol 44:41–49
dNemecek et al. Science 312:583–588
eDiagnostic SNPs according to Brown et al. PLoS One 8:e59237
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reproducibility of the genotyping results. Validation sam-
ples with missing alleles and inconsistent results were re-
extracted to investigate sample quality and amplification
inhibition. In addition to up-front assay validation, 11
duplicate samples were embedded in the final genotyping
run, blinded to the genotyping technician.
SNP panel analysis
Blastomyces spp. isolates with more than 1 missing allele
or low probability call, as defined by the instrument soft-
ware, (4 % missing genotype) were excluded from the
SNP portion of the study, in order to avoid classification
bias [15]. Species assignment of each isolate was based
on SNP ITS2_19 [7]. Allele frequencies, expressed as
percentages, were calculated for each SNP separately
between the Blastomyces spp.
Comparison of microsatellite and SNP genotyping
For both microsatellite typing and SNP typing data,
haplotypes were ascertained by identifying matching
samples, and subsumed to a single representative using
Genetic Analysis in Excel v6.41 [16]. Genetic structure
among the samples was analyzed separately for each
genotyping method using principle coordinate analysis
(PCoA) of the standardized covariance of the haplotypic
genetic distance as performed in Genetic Analysis in
Excel v6.41. All individual genotyping markers were
weighted equally for analysis of both microsatellite
typing and SNP typing data. The first and second
principle coordinate were plotted to graphically illustrate
clusters of haplotypes. For microsatellite data, the Bayes-
ian approach of the program STRUCTURE [17] was
used to predict the minimum number of genetic units or
clusters within the composite data. Analysis settings
included K (the putative number of genetic groups) ran-
ging from 1 to 12, the use of the admixture model, cor-
related allele frequencies between populations, lambda
of one, and the degree of admixture (alpha) was inferred
from the data as advised by the software’s manual. The
burn-in was set at 100,000 repetitions and the length of
each iteration was 100,000 repetitions with five iterations
of each K. The method of Evanno et al. [18] as estimated
using Structure Harvester [19] was used to assess the
most likely K given the data in conjunction with the
mean and variance of the ln probability of K. STRUC-
TURE output was used to assign individual haplotypes
to microsatellite genetic group. Locus-specific diversity
measures of the microsatellite genetic groups included:
number of alleles, number of unique alleles, and the
size and frequency of the most common allele. Gen-
etic group assignment by microsatellite analysis and
species assignment using the previously described
diagnostic SNP included in the panel [7] were com-
pared for correlation.
SNP associations in human isolates
For human isolates with both SNP genotyping and clin-
ical data available, associations between SNP and disease
presentation were analyzed using a Pearson’s chi-square
test, with α = 0.05.
Results
SNP panel validation
We observed 100 % concordance between Sanger sequen-
cing and SNP calls on the 102 previously known alleles on
the 12 isolate validation panel. Validation test results were
100 % reproducible when repeated in multiple batches,
demonstrated good amplification, and revealed clear-cut
genotyping results with all 28 assays. Furthermore, the 11
duplicate samples embedded in the genotyping project
showed 100 % agreement for all SNP calls.
SNP panel analysis
Three hundred twenty-three Blastomyces spp. isolates
(90 %) were successfully genotyped by SNP analysis, with
results obtained for at least 27 of 28 assays. The remaining
37 isolates were excluded from the SNP portion of the
study due to no amplification (n = 7), multiple no call
results (n = 20), or multiple heterozygous calls (n = 10).
Results of SNP genotyping are shown in Table 2. The tyro-
sinase_759 SNP was unable to be genotyped on 9 isolates,
making it the least robust assay. Three potential SNPs
(chs2_290, fads_622, TUB1_277), designed from GenBank
sequences, showed no sequence variation in the isolates
tested and were excluded from further analysis. The
remaining SNPs were bi-allelic as expected based on design
sequences, with the exception of arf6_240, which we
discovered to be tri-allelic. Three polymorphisms (ITS2_19,
drk1_586, and drk1_595) described by Brown et al. [7] as
being diagnostic between B. dermatitidis and B. gilchristii
were included in the assay. We found that results from
genotyping of drk1_586 and drk1_595 SNPs were not in
agreement with ITS2_19, as far as species assignment, on 2
isolates in this study (BD9911 and BD0503). Alternatively,
results from SNPs trypt-lig_922 and CoAligase_346
assigned all 323 isolates into B. gilchristii and B. dermatiti-
dis consistent with ITS2_19 genotyping. Based on ITS2_19,
146 (45 %) of the isolates in this study were B. dermatitidis
with the remaining 177 isolates (55 %) being B. gilchristii.
B. gilchristii isolates showed low allelic diversity (frequency
of ≥98 % for a single allele) at all but 1 locus, chs2_203,
which demonstrated a unique allele (G) at a frequency of
21 %. The majority of the diversity at this locus (73 %) was
due to 27 Canadian B. gilchristii isolates, which all had the
G allele. Alternatively, B. dermatitidis isolates showed
much more allelic diversity, with 7 loci exhibiting fre-
quencies of ≤90 % for a single allele. At most SNP loci
(15 of 25), the most frequent allele differed between B.
dermatitidis and B. gilchristii.
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Table 2 SNP genotyping results for 323 isolates, by Blastomyces spp. species (ITS2_19)
Marker Allele B. gilchristii (%) B. dermatitidis (%)
ITS2_19 Ca (n = 177) ITS2_19 Ta (n = 146)
132GAx11_108 A 176 (99) 14 [10]
G 1 [1] 132 (90)
alpha1_3glucan_2360b A 1c [1] 62 (42)
C 176 (99) 84 (58)
alpha1_3glucan_2386b C 1c [1] 146 (100)
G 176 (99) 0 (0)
APN2_1016b C 176 (99) 134 (92)
T 1c [1] 12 [8]
ARF_374b G 176 (99) 1 [1]
A 0 (0) 145 (99)
arf6_240 A 176 (99) 4 [3]
G 1 [1] 133 (91)
C 0 (0) 9 [6]
BAD1_4 A 176 (99) 1d [1]
G 1c [1] 145 (99)
BAD1_8b A 1c [1] 145 (99)
T 176 (99) 1d [1]
BAD1_9b C 176 (99) 1d [1]
G 1c [1] 145 (99)
b-glucosidase_1243b G 177 (100) 96 (66)
A 0 (0) 50 (34)
b-glucosidase_966 A 175 (99) 0 (0)
G 1c [1] 145 (99)
N/A 1 [1] 1d [1]
chit_2396b C 177 (100) 109 (75)
A 0 (0) 37 (25)
chs2_203 C 140 (79) 146 (100)
G 37e [21] 0 (0)
chs2_290f C 177 (100) 146 (100)
G 0 (0) 0 (0)
CoAligase_346 G 177 (100) 0 (0)
A 0 (0) 146 (100)
drk1_586a C 176 (99) 1 [1]
T 1 [1] 145 (99)
drk1_595a A 176 (99) 1d [1]
G 1c [1] 145 (99)
fads_622f T 177 (100) 146 (100)
C 0 (0) 0 (0)
hsp_764b A 176 (99) 13 [9]
C 1c [1] 133 (91)
pyrF_21 A 177 (100) 140 (96)
C 0 (0) 6 [4]
pyrF_99 C 177 (100) 144 (99)
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Comparison of microsatellite and SNP genotyping
The 323 Blastomyces spp. isolates with successful SNP
genotyping were subsumed to 73 unique haplotypes
(Additional file 2). SNP PCoA, shown in Fig. 1a demon-
strates clustering of the haplotypes into 2 primary
groups, with the exception of 2 intermediate haplotypes,
isolates BD9911 and BD0503 described above. The first
primary axis (Coordinate 1) explained 69 % of the vari-
ance between B. dermatitidis and B. gilchristii.
Microsatellite typing data was available on all 360 iso-
lates, including the 37 isolates that were excluded from
the SNP portion of the study. Two hundred twenty-four
unique microsatellite haplotypes were identified. For
microsatellite PCoA, the first primary axis (Coordinate
1) explained 25 % of the variance between the genetic
groups (Fig. 1b). STRUCTURE analysis of the unique
microsatellite haplotypes supported two genetic units in
the data (K = 2) based on the method of Evanno et al.
[18] and the linearity and variance of lnP (D). The indi-
vidual ancestry of each haplotype based on K = 2
revealed 62 haplotypes representing Gr 1 isolates and
162 haplotypes representing Gr 2 isolates. Examination
of microsatellite group-specific allelic diversity revealed
significant difference between the two genetic groups
(Table 3). Gr 1 isolates show low allelic diversity, ranging
from 1–7 alleles/locus (avg 3.7). Gr 2 isolates exhibit
more polymorphism, ranging from 4–18 alleles/locus
(avg 10.6). Across all loci, Gr 1 contained 14 alleles not
present in Gr 2; Gr 2 contained 200 alleles, not represented
in Gr 1. Comparison of microsatellite and SNP genotyping
showed that all isolates assigned to microsatellite Gr 1 by
STRUCTURE were B. gilchristii by ITS2_19 genotyping
and all isolates assigned to microsatellite Gr 2 by STRUC-
TURE were B. dermatitidis, with the exception of BD9911.
Within the data were 13 isolates with a majority q-value
(genetic membership threshold) of ≤90 % (Fig. 2), by
STRUCTURE analysis of microsatellite genotyping. Two
intermediate isolates had nearly equal genetic membership
in both groups; identified as BD9911 (genetic membership,
55 % Gr 2 and 45 % Gr 1) and BD0403 (genetic member-
ship, 52 % Gr 1 and 48 % Gr 2).
SNP associations in human isolates
SNP genotyping and clinical abstraction data were avail-
able on 240 human isolates. This was comprised of 151
B. gilchristii isolates (14 cases of disseminated disease
and 137 cases of exclusively pulmonary disease) and 89
cases of B. dermatitidis (31 cases of disseminated disease
and 58 cases of exclusively pulmonary disease). When
analyzed globally without regard to species, SNP alleles
were significantly different in cases of pulmonary vs dis-
seminated disease, at a p-value of <0.01 or less, for the
following SNPs: 132GAx11_108, alpha1_3glucan_2360,
alpha1_3glucan_2386, ARF_374, BAD1_4, BAD1_8,
BAD1_9, b-glucosidase_966, CoAligase_346, drk1_586,
drk1_595, hsp764, ITS2_19, septin1_1251, and trypt-
lig_922 (Additional file 3).
SNPs of interest in B. dermatitidis and B. gilchristii
Seven SNP loci in B. dermatitidis demonstrated within
species allelic diversity (frequency of ≤90 % for a single
allele). Only 6 of these were located within a gene
Table 2 SNP genotyping results for 323 isolates, by Blastomyces spp. species (ITS2_19) (Continued)
G 0 (0) 2 [1]
septin1_1251 A 175 (99) 17 [12]
G 2 [1] 129 (88)
trypt-lig_922 C 177 (100) 0 (0)
G 0 (0) 146 (100)
TUB1_18 C 177 (100) 144 (99)
T 0 (0) 2 [1]
TUB1_277f C 177 (100) 146 (100)
G 0 (0) 0 (0)
tyrosinase_759 T 174 (98) 132 (90)
A 0 (0) 8 [5]
N/A 3 [2] 6 [4]
urease_1503 A 177 (100) 69 (47)
G 0 (0) 77 (53)
aPublished by Brown et al
bSNP results in amino acid change
cIsolate BD9911
dIsolate BD0503
eIncludes 27 Canadian isolates
fExpected SNP based on genbank sequence
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coding region. One SNP locus in B. gilchristii met the
above criteria for diversity and was also in a coding
region. These SNPs were not analyzed for association
with disseminated and pulmonary disease presentation
within each Blastomyces spp. separately due to limited
statistical power. We did observe that the A urease_1503
allele (frequency 65 %) and G septin1_1251 allele (fre-
quency 90 %) were more often observed in B. dermatiti-
dis isolates resulting in cases of disseminated disease,
though these SNPs do not represent amino acid changes.
In addition, the A alpha1_2glucan_2360 allele, which
does result in an amino acid change, showed a slightly
Fig. 1 Principle coordinate analysis of the haplotypic pairwise covariance distance matrix. a Analysis of SNP data on 323 Blastomyces spp. isolates
subsumed to 73 unique haplotypes. The first primary axis (Coordinate 1) explained 69 % of the variance between B. dermatitidis and B. gilchristii.
b Analysis of microsatellite date on 360 isolates subsumed to 224 unique haplotypes. The first primary axis (Coordinate 1) explained 25 % of the
variance between the genetic groups. The 3 isolates identified in the figure were genetic intermediates by 1 or both genotyping methods
Frost et al. BMC Infectious Diseases  (2016) 16:509 Page 7 of 11
higher frequency (52 %) in cases of disseminated disease
caused by B. dermatitidis. In B. gilchristii, the G allele at
locus chs2_203 was found at a higher frequency in
patients with disseminated disease (43 %) as compared
to pulmonary disease (18 %) and in cases resulting in
death (38 %) as compared to no death (19 %). All 27
Canadian B. gilchristii isolates in this study exhibited the
G allele at this locus.
Discussion
This manuscript describes the development of a SNP
panel for genotyping Blastomyces spp. isolates. SNP
genotyping revealed more allelic diversity in B. dermati-
tidis isolates than B. gilchristii isolates, which is consist-
ent with previous studies [7]. In B. dermatitidis isolates,
7 markers demonstrated a frequency of ≤90 % for a
given allele in the population. B. gilchristii demonstrates
this level of diversity in only 1 marker (chs2_203), with
the remaining 27 markers showing >98 % of the popula-
tion having a single allele for a given marker. A large
percentage of the diversity shown in B. gilchristii at SNP
chs2_203 is due to 27 Canadian isolates (100 % of the
Canadian B. gilchristii isolates) that have the G allele at
that locus. Only 10 additional Wisconsin B. gilchristii
isolates (3 canine and 7 human) had the G allele at locus
chs2_203 suggesting regional genetic differences. Interest-
ingly, marker chs2_203, which demonstrates allelic diver-
sity in B. gilchristii, seems to be fixed in B. dermatitidis.
SNP genotyping with this panel largely supports the
division of Blastomyces spp. into 2 genetic groups, with
most isolates having alleles that are characteristic of
their species group. For 322/323 (99.7 %) isolates tested
Table 3 Summary of alleles by microsatellite genetic group
Group 1 Group 2
Locus nA
a Unique Most Common Alleleb Freqc nA
a Unique Most Common Alleleb Freqc
1 3 0 250 0.73 4 1 250 0.66
2 4 0 213 0.96 9 5 203 0.34
3 5 0 199 0.93 17 12 209 0.29
4 6 0 219 0.77 10 4 229 0.40
5 3 0 214 0.98 10 7 214 0.42
6 7 3 279 0.47 9 5 265 0.58
7 4 2 273 0.56 8 6 255 0.66
8 4 0 214 0.89 12 8 208 0.49
9 4 1 194 0.93 9 6 194 0.53
10 3 0 206 0.96 10 7 206 0.55
11 4 0 155 0.98 16 12 173 0.16
12 4 0 251 0.79 10 6 249 0.23
13 4 1 192 0.98 8 5 184 0.36
14 3 0 263 0.99 9 6 269 0.38
15 3 0 198 0.99 8 5 202 0.32
16 5 0 254 0.82 15 10 258 0.49
17 3 0 232 0.98 9 6 234 0.34
18 3 0 200 0.95 18 15 224 0.15
19 4 3 231 0.94 9 8 241 0.26
20 4 2 221 0.96 13 11 235 0.34
21 3 0 189 0.92 12 9 197 0.27
22 1 0 200 1.00 13 12 206 0.23
23 4 0 220 0.98 7 3 222 0.45
24 3 0 165 0.98 8 5 167 0.53
25 3 0 250 0.98 8 5 256 0.35
26 4 2 179 0.78 14 12 167 0.44
27 3 0 235 0.59 12 9 233 0.34
anA = number of alleles
bamplicon size in base pairs
cFreq = frequency of the most common allele
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by both genotyping methods in this study, microsatel-
lite genetic group assignment correlated with species
assignment based on ITS2_19 genotyping, with Gr 1
being equivalent to B. gilchristii and Gr 2 being equiva-
lent to B. dermatitidis. Several isolates in this study
were particularly interesting as they appear to be gen-
etic hybrids as determined by one or both methods of
genotyping (Fig. 2). It is clear that these isolates do not
fit neatly into the previously defined microsatellite or
species groups and that both of these genotyping
methods may be detecting hybridization between B.
dermatitidis and B. gilchristii. Brown et al. [7] were
only able to detect genetic recombination when it was
assessed separately within each Blastomyces sp. This
may be because only 78 samples were analyzed in that
study. In this study of 323 isolates, we found evidence
of potential recombination between the two species in
a small percentage of isolates. In order to accurately
assess genetic recombination between the two species,
a larger study of more genetic intermediate isolates
would be necessary.
Our SNP assay did not resolve the same level of gen-
etic variability within Blastomyces spp. isolates as
compared to our microsatellite assay. This is most cer-
tainly due to the higher mutation rate of microsatellite
regions. In fact, previous studies for forensics app-
lications in humans have shown that 3–4 SNPs are com-
parable to the genetic information in 1 microsatellite
marker [20, 21]. Taking this into account, our assays
were not directly comparable since they both had about
the same number of loci. Furthermore the target regions
of the genome were quite different between the assays
with almost all of the targets included on the SNP panel
being in coding regions. We must also point out that
our SNP assay is multiplexed in a single low-volume
reaction, whereas microsatellite typing in our lab is
performed in single individual reactions for each locus.
A SNP genotyping success rate of 90 % on isolates in
this study can be partially explained by the fact that
multiplex assays are more sensitive to factors such as
degraded DNA and carryover of inhibitors, both of
which we observed to a small degree in our samples. In
Fig. 2 Mean q-values (genetic membership threshold) from microsatellite STRUCTURE analysis for 13 “hybrid” haplotypes with K = 2
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summary, microsatellite typing had the disadvantages of
being labor intensive, low throughput, and expensive, yet
provides the most sensitivity for examining population
genetics questions. In contrast, SNP genotyping was
more cost effective, high throughput and could be used
to target gene coding regions, but was less sensitive for
resolving genetic differences that impact population
structure. However, both methods largely discriminate
the vast majority of isolates into one of the two distinct
Blastomyces spp.
A small number of isolates, dropped from the analysis
portion of the study, produced heterozygous SNP geno-
typing calls. In ~10 % of the DNA samples tested in this
study, we observed a 260/280 ratio of <1.8 (indicating
protein or phenol carry-over) or >2.0 (indicating RNA
carry-over), evidence of inhibitors, and/or degraded
DNA. This may be an explanation for the isolates with
1–2 “aggressive or low-probability” heterozygous calls as
defined by the software. Three of the isolates had het-
erozygous calls for almost half of the loci, including the
ITS2_19. For those isolates we propose that the patient
had a dual infection, which has been previously docu-
mented in the literature by us and another group [5, 22].
It is possible that we have more isolates in our biobank
that represent dual infections as we have no way of
knowing how often this occurs in patients.
The discovery of heterozygous SNP calls for some of
our isolates made us re-examine our hybrid isolates.
None of our hybrid isolates had any heterozygous SNP
calls and none of the isolates with heterozygous SNP
calls were hybrids by STRUCTURE analysis. Further-
more, we verified the mating type of each of the hybrid
isolates, tested previously for another study [5]. All thir-
teen hybrid isolates (Fig. 2) were previously tested by
PCR for mating type and all were positive for only 1
allele, either the high mobility group (HMG) locus or
alpha-box locus.
SNP analysis of all Blastomyces spp. isolates in human
cases revealed significant association between SNP and
disease location (exclusive pulmonary or disseminated)
in 15 of the 28 loci (Additional file 3). We expected this
result due to previously published associations between
the divergent genetic groups of Blastomyces spp. and
clinical features [6]. These results are included as sup-
plementary since they represent replicated support of
the already established association between genetics and
virulence. In fact, among the SNPs which are signifi-
cantly different between pulmonary and disseminated
disease are, a SNP within a microsatellite marker previ-
ously used for the association study referenced above [6]
and the ITS2 SNP reported by Brown et al. [7] as diag-
nostic between B. dermatitidis and B. gilchristii.
SNP association analysis in each of the Blastomyces
spp. separately, was unable to be performed due to
limited statistical power, although several SNPs of inter-
est were identified in B. dermatitidis and B. gilchristii for
future studies. The A urease_1503, G septin1_1251, and
A alpha1_2glucan_2360 alleles were more frequent in
cases of disseminated disease caused by B. dermatitidis.
In B. gilchristii, the G allele at locus chs2_203 was found
at a higher frequency in patients with disseminated dis-
ease as compared to pulmonary disease and in cases
resulting in death as compared to no death. Notably
death and dissemination in B. gilchristii infections did
not occur together frequently (only 2 of 13 cases) there-
fore these cases are not synonymous. It is important to
point out the impact of the Canadian isolates of B.
gilchristii on SNP allele frequency at locus chs2_203. All
27 Canadian B. gilchristii isolates in this study exhibited
the G allele at this locus, which is represented in the
United States (US) B. gilchristii isolates at a much
smaller frequency, about 3 %. Only 17 Canadian B.
gilchristii isolates are represented in Additional file 3,
due to incomplete clinical data on some isolates. The
clinical data that was available on these isolates showed
a higher incidence of both disseminated disease (n = 5,
30 %) and death (n = 4, 24 %) than US isolated B.
gilchristii cases in this study, or previously published
studies [6]. This SNP association is probably not very
meaningful from a virulence standpoint as it appears in
a housekeeping gene and does not result in an amino
acid change.
This study was limited to Blastomyces spp. isolates
with previous microsatellite typing and only represents a
limited geographic range of the organism. Additionally,
SNP association analysis to clinical presentation was
unable to be evaluated in B. dermatitidis and B. gilchris-
tii separately. Despite this, the results of this study
provide another tool for examining the genetic diversity
of Blastomyces spp.
Conclusions
This is the largest genotyping study of Blastomyces spp.
isolates and presents a new method for genetic analysis
with which to further explore the relationship between
the genetic diversity in Blastomyces spp. and clinical
disease presentation. We demonstrated that for 99.7 %
of isolates tested by both genotyping methods in this
study, microsatellite genetic group assignment correlated
with species assignment based on ITS2_19 genotyping,
with Gr 1 being equivalent to B. gilchristii and Gr 2
being equivalent to B. dermatitidis. We also discovered
potential evidence of infrequent recombination between
the 2 Blastomyces spp. In addition, several Blastomyces
spp. SNPs were identified as associated with dissemin-
ation or pulmonary disease presentation, but additional
work is needed to examine virulence SNPs separately
within B. dermatitidis and B. gilchristii.
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Additional files
Additional file 1: Primers for the primary PCR amplification of each
target in the 28 assay panel. List of forward and reverse primers for
amplification of each SNP target. (DOCX 15 kb)
Additional file 2: SNP genotyping haplotypes. Raw SNP genotyping
data obtained from all isolates, subsumed to 73 unique haplotypes.
(XLSX 21 kb)
Additional file 3: SNP associations for disease presentation and
mortality for 240 human isolates, globally for Blastomyces spp. Statistical
analysis of SNP status by pulmonary or disseminated disease
presentation. (DOCX 19 kb)
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